Novel approaches to clinical trial design in cancer neuroscience

Area of Science:

• Cancer Neuroscience
• Neuro-oncology
• Translational Cancer Research

Background:

• Emerging field of cancer neuroscience reveals bidirectional communication between the nervous system and cancer cells.
• Identifies novel therapeutic vulnerabilities in various malignancies.
• Significant challenges exist in translating these fundamental insights into clinical applications.

Purpose of the Study:

• To review challenges and strategies for translating cancer neuroscience discoveries into effective therapies.
• To propose innovative approaches including drug repurposing, biomarker development, and optimized clinical trial designs.
• To highlight potential therapeutic targets within neuroactive signaling pathways.

Main Methods:

• Review of existing literature on cancer neuroscience and therapeutic translation.
• Analysis of strategies for drug repurposing, focusing on neuroactive agents.
• Discussion of optimized clinical trial designs, including master protocols and window-of-opportunity trials.

Main Results:

• Drug repurposing of neuroactive agents targeting glutamatergic, adrenergic, and neurotrophic pathways offers an accelerated therapeutic path.
• Potential for repurposed agents with 'dual use' properties (toxicity mitigation and anti-tumor effects) identified.
• Master protocols and window-of-opportunity trials facilitate rapid validation of mechanisms and patient-centered outcomes.

Conclusions:

• Systematic, interdisciplinary approaches are crucial for translating cancer neuroscience insights into clinical advances.
• Focus on mitigating neurotoxicity and improving patient quality of life is paramount.
• Cancer neuroscience holds significant promise for developing novel therapies for treatment-resistant cancers.